Cue Biopharma, Inc. (38) | License Agreements (6)
Recent Contracts
-
First Amendment to the License Agreement, dated May 3, 2022, between Cue Biopharma, Inc. and MIL 40G, LLC
(Filed With SEC on August 4, 2022)
-
Rider to License Agreement, dated as of July 7, 2022, between Cue Biopharma, Inc. and MIL 40G, LLC
(Filed With SEC on August 4, 2022)
-
License Agreement, March 28, 2022
(Filed With SEC on March 30, 2022)
-
Third Amendment to License Agreement, dated October 22, 2021, by and between Cue Biopharma, Inc. and MIL 21E, LLC
(Filed With SEC on November 9, 2021)
-
First Amendment to the Amended and Restated License Agreement with Albert Einstein College of Medicine dated October 30, 2018
(Filed With SEC on March 9, 2021)
-
Second Amendment to License Agreement between the Registrant and MIL 21E, LLC
(Filed With SEC on June 26, 2020)